Recommend Using Actual Weight to Dose Enoxaparin in Obese Patients

We're getting questions about how to dose low-molecular-weight heparin (LMWH) for venous thromboembolism in obesity or renal impairment.

Dosing a LMWH, such as enoxaparin (Lovenox, etc), can be tricky in these cases. Usual doses may not be enough for obese patients...or they may accumulate and be too high in patients with renal impairment.

Obesity. Encourage techs to ask for weight when they see LMWH Rxs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote